The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lisopress 2.5 mg tablets



Gedeon Richter PlcPA1330/013/001

Main Information

Trade NameLisopress 2.5 mg tablets
Active SubstancesLisinopril
Dosage FormTablet
Licence HolderGedeon Richter Plc
Licence NumberPA1330/013/001

Group Information

ATC CodeC09AA ACE inhibitors, plain
C09AA03 lisinopril

Status

License statusWithdrawn
Withdrawn Date28/02/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back